Drug Profile
Measles and rubella virus vaccine - Beijing Minhai Biotechnology
Alternative Names: Lyophilised live attenuated measles and rubella combined vaccine - Beijing Minhai Biotechnology; MR attenuated combined vaccine - Beijing Minhai BiotechnologyLatest Information Update: 11 Sep 2015
Price :
$50
*
At a glance
- Originator Beijing Minhai Biotechnology
- Class Measles vaccines; Rubella vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Measles; Rubella